Thermo Fisher Scientific Applied Biosystems PureQuant Assays

Friday, 10 May, 2019 | Supplied by: Thermo Fisher Scientific


Applied Biosystems PureQuant Assays, from Thermo Fisher Scientific, are a family of assays that identify and quantify specific immune cell types in a mixed population of cells.

Designed for in-process and release testing of cell-based therapeutics, the assays measure genomic DNA methylation at sites that are unique to a specific immune cell type. With standards and controls built into each assay, they are ready to be seamlessly integrated into cell therapy workflows.

The assays’ core technology has been used for the identification and quantification of immune cell types for more than a decade. The qPCR method is easily standardised, enabling consistent results across multiple users, instruments and sites. The assays can be performed using fresh or frozen cells/gDNA, enabling flexibility.

The assays provide an innovative method for identity and purity testing of cell-based therapeutics, supporting cell therapy research, development and manufacturing. Regulatory support file is provided upon request, with established performance specifications following ICHQ2(R1) guidelines.

Online: thermofisher.com
Phone: 1300 735 292
Related Products

Cayman Chemical Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit

Cayman Chemical's Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit provides a...

Sphere Fluidics Cyto-Mine single-cell analysis system for cell line development

Sphere Fluidics' Cyto-Mine is a single-cell analysis platform that enables individual cells...

Bio-Rad Laboratories CFX Opus Deepwell Real-Time PCR Detection System

Bio-Rad Laboratories has launched the CFX Opus Deepwell Real-Time PCR Detection System to support...


  • All content Copyright © 2022 Westwick-Farrow Pty Ltd